Pacer Advisors, Inc. Boston Scientific Corp Transaction History

Pacer Advisors, Inc.

$41.8 Billion
Q3 2024

A detailed history of Pacer Advisors, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Pacer Advisors, Inc. holds 113,303 shares of BSX stock, worth $10.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

113,303

Previous 121,753 6.94%

Holding current value

$10.3 Million

Previous $9.38 Million 1.26%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$72.96 - $84.0 $616,512 - $709,800	-8,450 Reduced 6.94%	113,303 $9.49 Million
Q2 2024 Aug 13, 2024	SELL	$67.33 - $77.71 $1.87 Million - $2.16 Million	-27,758 Reduced 18.57%	121,753 $9.38 Million
Q1 2024 May 10, 2024	SELL	$57.6 - $68.62 $1.68 Million - $2 Million	-29,128 Reduced 16.31%	149,511 $10.2 Million
Q4 2023 Jan 16, 2024	BUY	$48.64 - $57.81 $3.85 Million - $4.58 Million	79,168 Added 79.59%	178,639 $10.3 Million
Q3 2023 Nov 13, 2023	BUY	$50.19 - $54.68 $93,905 - $102,306	1,871 Added 1.92%	99,471 $5.25 Million
Q2 2023 Jul 12, 2023	BUY	$49.72 - $54.64 $500,929 - $550,498	10,075 Added 11.51%	97,600 $5.28 Million
Q1 2023 May 02, 2023	BUY	$45.09 - $50.03 $3.71 Million - $4.12 Million	82,369 Added 1597.54%	87,525 $4.38 Million
Q4 2022 Feb 06, 2023	SELL	$39.56 - $47.22 $458,421 - $547,185	-11,588 Reduced 69.21%	5,156 $238,000
Q3 2022 Oct 18, 2022	SELL	$36.71 - $109.66 $46,805 - $139,816	-1,275 Reduced 7.08%	16,744 $648,000
Q2 2022 Aug 12, 2022	SELL	$35.24 - $47.1 $1.95 Million - $2.6 Million	-55,202 Reduced 75.39%	18,019 $672,000
Q1 2022 Apr 05, 2022	SELL	$40.9 - $45.1 $98,364 - $108,465	-2,405 Reduced 3.18%	73,221 $3.24 Million
Q4 2021 Feb 03, 2022	SELL	$38.07 - $44.87 $584,298 - $688,664	-15,348 Reduced 16.87%	75,626 $3.21 Million
Q3 2021 Oct 15, 2021	BUY	$41.23 - $45.88 $60,401 - $67,214	1,465 Added 1.64%	90,974 $3.95 Million
Q2 2021 Jul 21, 2021	BUY	$38.58 - $44.24 $441,316 - $506,061	11,439 Added 14.65%	89,509 $3.83 Million
Q1 2021 Apr 05, 2021	SELL	$35.27 - $39.67 $280,643 - $315,654	-7,957 Reduced 9.25%	78,070 $3.02 Million
Q4 2020 Jan 20, 2021	SELL	$33.15 - $41.97 $830,606 - $1.05 Million	-25,056 Reduced 22.56%	86,027 $3.09 Million
Q3 2020 Oct 19, 2020	SELL	$34.44 - $42.23 $683,496 - $838,096	-19,846 Reduced 15.16%	111,083 $4.24 Million
Q2 2020 Jul 29, 2020	BUY	$30.19 - $39.11 $3.95 Million - $5.12 Million	130,929 New	130,929 $4.6 Million
Q1 2020 Apr 23, 2020	SELL	$25.83 - $45.71 $4.16 Million - $7.37 Million	-161,188 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$37.87 - $45.37 $182,912 - $219,137	4,830 Added 3.09%	161,188 $7.29 Million
Q3 2019 Oct 10, 2019	BUY	$40.31 - $43.45 $819,986 - $883,859	20,342 Added 14.96%	156,358 $6.36 Million
Q2 2019 Aug 12, 2019	BUY	$34.91 - $42.98 $437,282 - $538,367	12,526 Added 10.14%	136,016 $5.85 Million
Q1 2019 Apr 10, 2019	BUY	$32.91 - $40.75 $4.06 Million - $5.03 Million	123,490 New	123,490 $4.74 Million
Q4 2018 Feb 13, 2019	SELL	$31.73 - $39.04 $2.31 Million - $2.84 Million	-72,860 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$32.83 - $38.63 $312,968 - $368,259	9,533 Added 15.05%	72,860 $2.81 Million
Q2 2018 Aug 14, 2018	BUY	$26.84 - $34.32 $286,651 - $366,537	10,680 Added 20.29%	63,327 $2.07 Million
Q1 2018 May 14, 2018	BUY	$25.2 - $28.54 $148,402 - $168,072	5,889 Added 12.59%	52,647 $1.44 Million
Q4 2017 Feb 14, 2018	BUY	$24.79 - $29.8 $472,100 - $567,511	19,044 Added 68.72%	46,758 $1.16 Million
Q3 2017 Nov 08, 2017	BUY	$26.26 - $29.17 $727,769 - $808,417	27,714	27,714 $808,000

Others Institutions Holding BSX

# of Institutions

1,542

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $130B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Boston Scientific Corp Transaction History